ORBUSNEICH (06929) announces its annual performance, with a shareholder profit of 41.89 million US dollars, representing a 5.49% year-on-year increase.

16:40 12/03/2026

Yeju Medical (06929) released its annual performance for the year ending December 31, 2025. The group achieved a revenue of 180 million US dollars during the period, an increase of 9.97% year-on-year. The company's attributable profit reached 41.899 million US dollars, a year-on-year increase of 5.49%, with a basic earnings per share of 5.09 cents US dollars.

ORBUSNEICH (06929) released its annual performance for the year ending December 31, 2025. The group achieved a revenue of 180 million US dollars, an increase of 9.97% compared to the previous year. The company's attributable profit was 41.899 million US dollars, an increase of 5.49% compared to the previous year. Basic earnings per share were 5.09 US cents. The announcement stated that gross profit increased by 7.0% from 115 million US dollars in the year ending December 31, 2024 to 122 million US dollars in the same period in 2025. The increase was mainly attributed to an increase in sales volume during the year.

WHARF HOLDINGS (00004): Peter Tung to retire as independent non-executive director.

WINSHINE SCI(00209) issues a profit warning, expecting the shareholders' attributable loss for the full year 2025 to not exceed HK$95 million.

Xiaomi-W (01810) spent 76.9093 million Hong Kong dollars to repurchase 230,760 shares on March 12th.

WHARF HOLDINGS (00004): Peter Tung to retire as independent non-executive director.

WINSHINE SCI(00209) issues a profit warning, expecting the shareholders' attributable loss for the full year 2025 to not exceed HK$95 million.

Xiaomi-W (01810) spent 76.9093 million Hong Kong dollars to repurchase 230,760 shares on March 12th.